Related references
Note: Only part of the references are listed.Glucagon-like peptide-1 receptor action in the vasculature
Malak Almutairi et al.
PEPTIDES (2019)
Role of Cytochrome p450 and Soluble Epoxide Hydrolase Enzymes and Their Associated Metabolites in the Pathogenesis of Diabetic Cardiomyopathy
Zaid H. Maayah et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2019)
GLP-1 analog liraglutide-induced cardiac dysfunction due to energetic starvation in heart failure with non-diabetic dilated cardiomyopathy
Aya Shiraki et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Akt activation: A potential strategy to ameliorate insulin resistance
Zhengyi Zhang et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction
Linda Alex et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2018)
Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017
Thomas R. Einarson et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity
Guanghong Jia et al.
CIRCULATION RESEARCH (2018)
Glucagon-like peptide-1 receptor mediated control of cardiac energy
Rami Al Batran et al.
PEPTIDES (2018)
Cardiac-Specific Deletion of Pyruvate Dehydrogenase Impairs Glucose Oxidation Rates and Induces Diastolic Dysfunction
Keshav Gopal et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2018)
Protein S-glutathionylation alters superoxide/hydrogen peroxide emission from pyruvate dehydrogenase complex
Marisa O'Brien et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Glucagon-Like Peptide 1 Receptor Activation Augments Cardiac Output and Improves Cardiac Efficiency in Obese Swine After Myocardial Infarction
Daniel J. Sassoon et al.
DIABETES (2017)
Inhibition of Dipeptidyl Peptidase-4 Impairs Ventricular Function and Promotes Cardiac Fibrosis in High Fat-Fed Diabetic Mice
Erin E. Mulvihill et al.
DIABETES (2016)
Lipotoxicity in obesity and diabetes-related cardiac dysfunction
Igor Zlobine et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2016)
The Cardiovascular Biology of Glucagon-like Peptide-1
Daniel J. Drucker
CELL METABOLISM (2016)
2-Oxoglutarate dehydrogenase is a more significant source of O2•-/H2O2 than pyruvate dehydrogenase in cardiac and liver tissue
Ryan J. Mailloux et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction A Randomized Clinical Trial
Kenneth B. Margulies et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Increasing Pyruvate Dehydrogenase Flux as a Treatment for Diabetic Cardiomyopathy: A Combined C-13 Hyperpolarized Magnetic Resonance and Echocardiography Study
Lydia M. Le Page et al.
DIABETES (2015)
The Impact of Chronic Liraglutide Therapy on Glucagon Secretion in Type 2 Diabetes: Insight From the LIBRA Trial
Caroline K. Kramer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Cardioprotection Resulting from Glucagon-Like Peptide-1 Administration Involves Shifting Metabolic Substrate Utilization to Increase Energy Efficiency in the Rat Heart
Karpagam Aravindhan et al.
PLOS ONE (2015)
Cardiomyocyte glucagon receptor signaling modulates outcomes in mice with experimental myocardial infarction
Safina Ali et al.
MOLECULAR METABOLISM (2015)
Deciphering ventricular GLP-1 action: time for a change of heart
John R. Ussher
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2014)
Cardiovascular Actions of Incretin-Based Therapies
John R. Ussher et al.
CIRCULATION RESEARCH (2014)
Identification and Characterization of GLP-1 Receptor-Expressing Cells Using a New Transgenic Mouse Model
Paul Richards et al.
DIABETES (2014)
The Pyruvate Dehydrogenase Complexes: Structure-based Function and Regulation
Mulchand S. Patel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Inactivation of the cardiomyocyte glucagon-like peptide-1 receptor (GLP-1R) unmasks cardiomyocyte-independent GLP-1R-mediated cardioprotection
John R. Ussher et al.
MOLECULAR METABOLISM (2014)
Akt/PKB activation and insulin signaling: a novel insulin signaling pathway in the treatment of type 2 diabetes
Richard W. A. Mackenzie et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2014)
Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus
Daniel Lorber
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2014)
Treatment with the 3-Ketoacyl-CoA Thiolase Inhibitor Trimetazidine Does Not Exacerbate Whole-Body Insulin Resistance in Obese Mice
John R. Ussher et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action
Jonathan E. Campbell et al.
CELL METABOLISM (2013)
A Glucagon-Like Peptide-1 Analog Reverses the Molecular Pathology and Cardiac Dysfunction of a Mouse Model of Obesity
Mohammad Hossein Noyan-Ashraf et al.
CIRCULATION (2013)
GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure
Minsuk Kim et al.
NATURE MEDICINE (2013)
Agonist-Induced Hypertrophy and Diastolic Dysfunction Are Associated With Selective Reduction in Glucose Oxidation A Metabolic Contribution to Heart Failure With Normal Ejection Fraction
Jun Mori et al.
CIRCULATION-HEART FAILURE (2012)
The impact of current and novel anti-diabetic therapies on cardiovascular risk
John R. Ussher et al.
FUTURE CARDIOLOGY (2012)
Glucagon-Like Peptide-1 Increases Myocardial Glucose Uptake via p38α MAP Kinase-Mediated, Nitric Oxide-Dependent Mechanisms in Conscious Dogs With Dilated Cardiomyopathy
Siva Bhashyam et al.
CIRCULATION-HEART FAILURE (2010)
Insulin-Stimulated Cardiac Glucose Oxidation Is Increased in High-Fat Diet-Induced Obese Mice Lacking Malonyl CoA Decarboxylase
John R. Ussher et al.
DIABETES (2009)
Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats
Pal Pacher et al.
NATURE PROTOCOLS (2008)
Impact of Gender on the Myocardial Metabolic Response to Obesity
Linda R. Peterson et al.
JACC-CARDIOVASCULAR IMAGING (2008)
Cardiac energy metabolism in obesity
Gary D. Lopaschuk et al.
CIRCULATION RESEARCH (2007)
Diabetic cardiomyopathy revisited
Sihem Boudina et al.
CIRCULATION (2007)
Regulation of the pyruvate dehydrogenase complex
MS Patel et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity
J Buchanan et al.
ENDOCRINOLOGY (2005)
Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women
LR Peterson et al.
CIRCULATION (2004)
Share Paper
